AlleyeOne is aimed at Alleye providers who want to offer their customers smart screening for retinal diseases. AlleyeOne detects diseases of the retina and is specialized in the early detection of age-related macular degeneration (AMD) and diabetic macular edema (DME).
Although the diseases cannot be stopped completely, their progression can be slowed down. The earlier you treat, the longer you can maintain your vision. Therefore, it is important that your customers use AlleyeOne to detect these diseases early. We recommend using the AlleyeOne test twice a year for risk groups (people 50+).